Bayesian Capital Management’s Athenahealth, Inc. ATHN Stock Holding History

Bayesian Capital Management’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,562	Closed	-$1.26M	–	860
2018 Q4	$1.26M	Buy	+9,562	New	+$1.22M	0.26%	105
2018 Q2	–	Sell	-6,855	Closed	-$980K	–	822
2018 Q1	$980K	Buy	6,855 +1,200	+21%	+$164K	0.25%	125
2017 Q4	$752K	Sell	5,655 -7,500	-57%	-$958K	0.15%	228
2017 Q3	$1.64M	Buy	+13,155	New	+$1.81M	0.39%	66
2016 Q1	–	Sell	-2,000	Closed	-$322K	–	475
2015 Q4	$322K	Buy	+2,000	New	+$309K	0.46%	82

Bayesian Capital Management's ATHN Position: Q1 2019 in Review

Bayesian Capital Management sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 9,562 shares — an estimated $1.26M sold.

Bayesian Capital Management first reported a position in ATHN in Q4 2015 and held it in 5 quarters. The position peaked at $1.64M in Q3 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Bayesian Capital Management reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Bayesian Capital Management sold 9,562 Athenahealth, Inc. shares in Q1 2019, an estimated $1.26M.
Bayesian Capital Management first reported a position in Athenahealth, Inc. in Q4 2015 and held it in 5 quarters.
Bayesian Capital Management's Athenahealth, Inc. position peaked at $1.64M in Q3 2017.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.